SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-202879
Filing Date
2024-08-19
Accepted
2024-08-19 17:13:59
Documents
20
Period of Report
2024-08-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d816262d8k.htm   iXBRL 8-K 34442
2 EX-1.1 d816262dex11.htm EX-1.1 180247
3 EX-4.1 d816262dex41.htm EX-4.1 72560
4 EX-5.1 d816262dex51.htm EX-5.1 19093
5 EX-99.1 d816262dex991.htm EX-99.1 9889
9 GRAPHIC g816262g0819053733565.jpg GRAPHIC 3322
10 GRAPHIC g816262g0819221127428.jpg GRAPHIC 2373
11 GRAPHIC g816262g0819221755969.jpg GRAPHIC 1790
  Complete submission text file 0001193125-24-202879.txt   538141

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA phat-20240819.xsd EX-101.SCH 2868
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE phat-20240819_lab.xml EX-101.LAB 18737
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phat-20240819_pre.xml EX-101.PRE 11719
22 EXTRACTED XBRL INSTANCE DOCUMENT d816262d8k_htm.xml XML 3775
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39094 | Film No.: 241221588
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)